Delivery Order SPE2DB20D1100-SPE2DB25FE1G3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Depakote DR 125 mg sprinkle capsules (100-count units) with a ceiling value of $3,467.93. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $1,921.72. The award was made on July 30, 2025, with a completion date of July 31, 2025, under a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Depakote DR 125 mg sprinkle capsules (100-count unit) valued at $1,458.55. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $3,092.44 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,358.37 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with a completion deadline of July 21, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a direct procurement of pharmaceutical inventory to support federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,605.84 to AmerisourceBergen Drug Corp for 100 sprinkle capsules of Depakote DR 125 mg, an anticonvulsant and mood-stabilizing medication commonly used in military and veteran healthcare systems. This non-set-aside contract reflects a firm fixed price arrangement with a place of performance in Conshohocken, Pennsylvania, and was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The delivery order...
- The Defense Logistics Agency awarded a $2,914.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 125mg Depakote Sprinkle capsules. Amerisourcebergen will deliver 100 count bottles of the generic anti-seizure medication to a facility in Conshohocken, Pennsylvania by August 14th, 2023 in support of Department of Defense logistics operations. As the prime contractor, Amerisourcebergen will likely fulfill the order from its own inventory and distribution network, with no...
- The Defense Logistics Agency awarded a $441,280 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will supply 100 boxes containing 125 milligram tablets of the anticonvulsant drug Depakote Sprinkle Capsules to support the Department of Defense's medical readiness programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in mid-July 2023. No...
- This federal contract award, valued at $1,064.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Depakote DR 125 mg sprinkle capsules, a medication used for various neurological and psychiatric conditions. The contract has an ultimate completion date of August 10, 2022 and is a Firm Fixed Price (FFP) agreement. The award is not associated with...
- This is a $1,147.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a generic pharmaceutical product. The contract has an ultimate completion date of April 8, 2025 and does not utilize any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1G3Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $5,463.37. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 19, 2025, and performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply pharmaceuticals and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Depakote, a neurological treatment medication, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles that address ongoing pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/18/25 |